News FDA grants fast review for Roche's haemophilia drug Emicizumab is firm's latest blockbuster hopeful
News Amicus to file Fabry drug after FDA changes mind Regulator drops demand for further phase 3 trial.
News Shire injunction blocks Roche's 'misleading' statements on h... Shire alleges trial info "unlawfully disparages" its product.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.